ALXA

Alexza Pharmaceuticals, Inc. News Headlines

$1.48
*  
0.08
5.71%
Get ALXA Alerts
*Delayed - data as of Dec. 26, 2014 14:57 ET  -  Find a broker to begin trading ALXA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Insomnia Found to Cost $63 Billion a Year - Here are 4 Companies to Treat It
10/11/2011 6:09:06 PM - Kapitall


Alexza's Agitation Drug Back Under Review - Trade the Upcoming Catalysts
8/9/2011 2:11:00 PM - Seeking Alpha


5 Healthcare Company Updates Released Wednesday
7/28/2011 8:36:00 AM - Seeking Alpha


Alexza Pharmaceuticals: Stock Moving Events for Second Half 2011
7/19/2011 4:42:00 PM - Seeking Alpha


6 Healthcare Companies With July Catalysts
6/30/2011 4:01:00 PM - Seeking Alpha


Biotech Catalysts for Third Quarter
6/24/2011 6:34:00 PM - Seeking Alpha


12 Rallying Stocks Under $5 Undervalued by Analysts
6/24/2011 5:06:00 PM - Seeking Alpha


Biotech: Some CRL Recipients to Consider
5/16/2011 10:18:00 AM - Seeking Alpha


Dow Nears 2011 Highs
3/31/2011 3:29:00 AM - Seeking Alpha


All Eyes on Alexza as Company Prepares to Re-File Drug Application
3/16/2011 1:59:00 PM - Seeking Alpha


The Market Seems to Disagree With Alexza's Promising News
1/19/2011 3:39:00 AM - Seeking Alpha


A New Deal for Alexza Could Present Opportunity for Investors
1/19/2011 2:56:00 AM - Seeking Alpha


Biotech’s Top and Bottom 10 From 2010
1/6/2011 10:58:00 AM - Seeking Alpha


FDA Locked And Loaded For MELA Sciences (MELA, VVUS, ARNA, ALXA, MDT, SYK)
11/16/2010 12:27:00 PM - Investopedia


Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug: Biotech's Latest Tribulations
10/17/2010 8:39:00 AM - Seeking Alpha


Alexza's CRL Offers Long Term Investment Opportunity
10/12/2010 11:13:00 AM - Seeking Alpha


Risks vs. Benefits in Holding Alexza Through Approval of AZ-004
10/11/2010 6:55:00 AM - Seeking Alpha


Alexza Pharmaceuticals: Hold, Sell, or Put?
10/3/2010 9:47:00 AM - Seeking Alpha


Roche Dominates the Biotech Deal Flow
8/30/2010 6:43:00 AM - Seeking Alpha


Alexza Pharma Clears Hurdles Towards Approval for Agitation Drug
8/18/2010 1:18:00 AM - Seeking Alpha


Two IPOs Brave the Markets, Two Enter the Queue: Biotech's Latest Deals
8/8/2010 8:34:00 AM - Seeking Alpha


Alexza Financing Will Help Near-Term Milestones and Product Launch
8/7/2010 11:15:00 AM - Seeking Alpha


A Closer Look at the Biovail - Valeant Merger
6/23/2010 2:34:39 AM - SeekingAlpha


VC-Backed Life Sciences Companies Get Fresh Cash
5/30/2010 11:19:00 AM - Seeking Alpha


Medtech Brings in Life Sciences Venture Dollars
5/9/2010 6:40:00 PM - Seeking Alpha